Understanding myeloproliferative neoplasms (MPN)

Leukaemia Care are hosting this patient information webinar to explain myeloproliferative neoplasms (MPN).

14 September 2023

On Monday 14th September at 6pm we’ll be talking all things MPN, including what different conditions make up this group, how they are diagnosed and managed as well as the different treatment options available. The webinar will also focus on what a patient can expect when living with an MPN and what support and care is available to help you and your family if you experience a challenging time.

Register for the webinar

We will be joined by

Kirsty Crozier, Haematology Advanced Clinical Practitioner, Great Western Hospitals NHS Foundation Trust

How do I join the webinar? 

The webinar is being hosted on Zoom and Facebook, meaning you can choose a platform to suit you. Zoom is the best place to ask questions, but if you join via Facebook we will try and get all the questions sent over to our panel; however, please expect a delay.

Information on how to join via Zoom or Facebook is below. 

Watch via Zoom

To join via Zoom, all you need to do is register your attendance before the webinar starts. You will then receive an email inviting you to join the webinar on the day.

Watch via Facebook

To join via Facebook, all you need is a Facebook account. Once logged in head to Leukaemia Care’s Facebook page at the time of the webinar and find the live video (it will be at the top of our feed).

Please note, we will not be able to give individual medical advice. You will be directed to your own clinical team if we cannot answer your question in the webinar.

Due to the large amount of registrants, we cannot guarantee that everyone’s questions will be answered, but we will try and do our best in the time frame that we have.

If you have any issues registering via Zoom or issues on the day, please get in touch by emailing support@leukaemiacare.org.uk.

What is neutropenia and a healthy diet?

Treatment for all types of cancer acts to ‘kill off’ the harmful tumour cells in the body, and in doing so the treatment can also destroy healthy cells.

Read More